Cosmo Pharmaceuticals NV (CMOPF)
138.19
-5.31
(-3.70%)
USD |
OTCM |
Mar 05, 15:43
Cosmo Pharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amarin Corp. Plc | -- |
| Jazz Pharmaceuticals Plc | -372.16M |
| Prothena Corp. Plc | 0.002M |
| Iterum Therapeutics Plc | -0.0126M |
| GH Research Plc | 10.46M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | 73.35M |
| Free Cash Flow Yield | 3.24% |